Načítá se...
Pramipexole Extended Release: A Novel Treatment Option in Parkinson's Disease
Pramipexole, the most commonly prescribed dopamine agonist worldwide, meanwhile serves as a reference substance for evaluation of new drugs. Based on numerous clinical data and vast experiences, efficacy and safety profiles of this non-ergoline dopamine agonist are well characterized. Since October...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE-Hindawi Access to Research
2010
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3010659/ https://ncbi.nlm.nih.gov/pubmed/21209705 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4061/2010/612619 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|